We have located links that may give you full text access.
Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years.
European Journal of Pharmacology 2018 October 6
Addiction pharmacotherapy aims to prevent drug abstinence symptoms, reduce drug craving and relapse, and normalize physiologic functions disrupted by chronic use of the drug. During the last 50 years, there has been an enormous revolution in pharmacotherapy for drug addiction. From abstinence as practically the only treatment option available, there are now multiple drugs on the market that have proved their efficacy in treating opiate and alcohol disorders. The present review will focus on the pharmacological treatments of the drugs whose consumption most affects individuals and society: alcohol and opiates. We will review the drugs most widely prescribed to prevent relapse and maintain abstinence, as well as those designed to reduce the consumption of short-acting drugs (e.g. maintenance therapies) since the 1960s. Methadone and buprenorphine are the most widely used maintenance therapies for opiate addicts, although new pharmacological depot systems of naltrexone are showing promising results. For alcohol use disorders, acamprosate, nalmefene and naltrexone are replacing disulfiram prescriptions, and a wide variety of new products are currently under study. The number of new pharmacological targets already on clinical trials and the advanced new ways to administer classic therapies can improve the success rate of the pharmacotherapy for opioid and alcohol addiction.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app